EXACT Sciences Aktie
WKN: 590273 / ISIN: US30063P1057
17.11.2023 13:35:59
|
Exact Sciences Files Lawsuit Against Geneoscopy For Infringing Patented Technology
(RTTNews) - Exact Sciences Corp. (EXAS) has filed a lawsuit against Geneoscopy, Inc. in the United States District Court for the District of Delaware. The lawsuit seeks damages and a court order to stop Geneoscopy from making, using, selling, or offering for sale Geneoscopy's ColoSense product or otherwise infringing on Exact Sciences' U.S. Patent.
Exact Sciences utilizes the patented technology in its Cologuard stool DNA-based colorectal cancer screening test. The patent covers clinically important methods for processing collection of fecal samples at home.
For More Such Health News, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu EXACT Sciences Corp.mehr Nachrichten
Analysen zu EXACT Sciences Corp.mehr Analysen
Aktien in diesem Artikel
EXACT Sciences Corp. | 40,82 | -0,44% |
|